STOCK TITAN

Braskem reports Recurring EBITDA of R$2.4 billion in 3Q24, 44% higher compared to 2Q24

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Braskem (NYSE: BAK), the Americas' largest resin producer and global biopolymers leader, reported strong financial results for Q3 2024. The company achieved a Recurring EBITDA of US$432 million, marking a 35% increase from Q2 2024 and a 130% rise from Q3 2023. The company maintained a robust cash position of US$2.4 billion, providing coverage for debt maturities over the next 52 months. Operating Cash Generation improved to US$75 million (R$416 million), showing an increase from the previous quarter.

Loading...
Loading translation...

Positive

  • Recurring EBITDA increased 35% QoQ and 130% YoY to US$432 million
  • Strong cash position of US$2.4 billion covering 52 months of debt maturities
  • Positive Operating Cash Generation of US$75 million

Negative

  • None.

News Market Reaction 1 Alert

-4.75% News Effect

On the day this news was published, BAK declined 4.75%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Highest quarterly Recurring EBITDA since 2Q22

SÃO PAULO, Nov. 7, 2024 /PRNewswire/ --  BRASKEM S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK), the largest resin producer in the Americas and the world's leading biopolymers producer, presents its 3Q24 Earnings Release.

3Q24 HIGHLIGHTS 

CONSOLIDATED

  • Recurring EBITDA of US$432 million, about 35% higher than in 2Q24 and 130% higher than in 3Q23.
  • Cash position of US$2.4 billion, ensuring coverage of debt maturities over the next 52 months.
  • Operating Cash Generation of US$75 million, around R$416 million, higher than 2Q24.

The full earnings release is available on the Company's IR website: www.braskem-ri.com.br/en

Braskem will host conference calls to discuss its Results Thursday, November 7 at 09:00 a.m. US ET.

Additional information may be obtained from the Investor Relations Department at +55 11 3576-9531 or braskem-ri@braskem.com.br.

 

Cision View original content:https://www.prnewswire.com/news-releases/braskem-reports-recurring-ebitda-of-r2-4-billion-in-3q24--44-higher-compared-to-2q24--302298679.html

SOURCE Braskem S.A.

FAQ

What was Braskem's (BAK) Recurring EBITDA in Q3 2024?

Braskem's Recurring EBITDA in Q3 2024 was US$432 million, representing a 35% increase from Q2 2024 and a 130% increase from Q3 2023.

How much cash does Braskem (BAK) have on hand as of Q3 2024?

Braskem maintained a cash position of US$2.4 billion, which covers debt maturities for the next 52 months.

What was Braskem's (BAK) Operating Cash Generation in Q3 2024?

Braskem's Operating Cash Generation in Q3 2024 was US$75 million (approximately R$416 million), showing an improvement from Q2 2024.
Braskem Sa

NYSE:BAK

BAK Rankings

BAK Latest News

BAK Latest SEC Filings

BAK Stock Data

1.14B
398.48M
3.57%
0.86%
Chemicals
Basic Materials
Link
Brazil
São Paulo